Ravi Vij, MD, MBA, offered additional information about the use of various regimens aimed to treat patients with high-risk, newly diagnosed multiple myeloma, that were read out at the 2022 ASH Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results